Cytonus Technologies Corsa
  • Our science
  • Our team
  • News
  • Video
  • Our commitment

Archive for March, 2022

Cytonus Therapeutics to Present Preclinical Data for Cargocyte™ CA-IL-12 for Treating Immune Checkpoint Inhibitor-Resistant Late Stage Metastatic Cancers at AACR 2022

Mar 29 2022

SAN DIEGO (BUSINESS WIRE) MARCH 29, 2022 Cytonus Therapeutics Inc. (Cytonus), a biotechnology company developing therapeutic products for targeted delivery in vivo,…

Recent Posts

  • Cytonus Therapeutics to Present Preclinical Data for Cargocyte™ CA-IL-12 for Treating Immune Checkpoint Inhibitor-Resistant Late Stage Metastatic Cancers at AACR 2022
  • Cytonus announces Nature Biomedical Engineering publication
  • Tales of a Startup: Cytonus Therapeutics Inc.
  • Cytonus expands its Scientific Advisory Board with City of Hope’s Stephen Forman, MD and NYU’s Robert Schneider, PhD
  • Cytonus appoints Allergan executive Manisha Narasimhan, Ph.D. to its Board of Directors

Archives

  • March 2022
  • December 2021
  • January 2021
  • March 2020
  • February 2020
  • January 2020
  • April 2019
  • March 2019
  • February 2019

Categories

  • Events
  • In the news
  • Interviews & Spotlights
  • Partnerships
  • Q&A
  • The Cytonus team
Copyright © 2021 Cytonus Therapeutics, Inc. All rights reserved.    |     Terms of use